111 related articles for article (PubMed ID: 35403372)
1. Pretreatment frailty is an independent prognostic factor among elderly patients with B-cell lymphoma undergoing immunochemotherapy: A prospective observational cohort study in Taiwan.
Hung YS; Chang H; Wang PN; Kuo MC; Su YJ; Hung CY; Hsueh SW; Yeh KY; Ho YW; Chou WC
Asia Pac J Clin Oncol; 2023 Feb; 19(1):62-70. PubMed ID: 35403372
[TBL] [Abstract][Full Text] [Related]
2. Application of comprehensive geriatric assessment in predicting early mortality among elder patients with B-cell lymphoma receiving immunochemotherapy.
Chou WC; Chang H; Wang PN; Kuo MC; Wu JH; Lin TL; Su YJ; Kao HW; Ou CW; Hung CY; Hsueh SW; Hung YS
Eur J Haematol; 2020 Oct; 105(4):399-407. PubMed ID: 32472712
[TBL] [Abstract][Full Text] [Related]
3. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
Pastore A; Jurinovic V; Kridel R; Hoster E; Staiger AM; Szczepanowski M; Pott C; Kopp N; Murakami M; Horn H; Leich E; Moccia AA; Mottok A; Sunkavalli A; Van Hummelen P; Ducar M; Ennishi D; Shulha HP; Hother C; Connors JM; Sehn LH; Dreyling M; Neuberg D; Möller P; Feller AC; Hansmann ML; Stein H; Rosenwald A; Ott G; Klapper W; Unterhalt M; Hiddemann W; Gascoyne RD; Weinstock DM; Weigert O
Lancet Oncol; 2015 Sep; 16(9):1111-1122. PubMed ID: 26256760
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B-cell lymphoma receiving rituximab-chemotherapy combinations.
Ong DM; Ashby M; Grigg A; Gard G; Ng ZY; Huang HE; Chong YS; Cheah CY; Devitt B; Chong G; Loh Z; Mo A; Hawkes EA
Br J Haematol; 2019 Oct; 187(1):73-81. PubMed ID: 31206608
[TBL] [Abstract][Full Text] [Related]
5. Impact of Frailty on Treatment Outcome in Patients With Locally Advanced Esophageal Cancer Undergoing Concurrent Chemoradiotherapy.
Huang YH; Hung YS; Lai CC; Ho MM; Yeh KY; Yang C; Lu CH; Tseng CK; Tsang NM; Hung CY; Hsueh SW; Chang PH; Ho YW; Lin YC; Chou WC
Anticancer Res; 2021 Oct; 41(10):5213-5222. PubMed ID: 34593474
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure.
Vidán MT; Blaya-Novakova V; Sánchez E; Ortiz J; Serra-Rexach JA; Bueno H
Eur J Heart Fail; 2016 Jul; 18(7):869-75. PubMed ID: 27072307
[TBL] [Abstract][Full Text] [Related]
7. An Easy Assessment of Frailty at Baseline Independently Predicts Prognosis in Very Elderly Patients With Acute Coronary Syndromes.
Alegre O; Formiga F; López-Palop R; Marín F; Vidán MT; Martínez-Sellés M; Carol A; Sionis A; Díez-Villanueva P; Aboal J; Palau-Vendrel A; Bueno H; Rivera AP; Sanchís J; Abu-Assi E; Corbí M; Castillo JC; Bañeras J; González-Salvado V; Cequier À; Ariza-Solé A;
J Am Med Dir Assoc; 2018 Apr; 19(4):296-303. PubMed ID: 29153753
[TBL] [Abstract][Full Text] [Related]
8. Prognosis Impact of Frailty Assessed by the Edmonton Frail Scale in the Setting of Acute Coronary Syndrome in the Elderly.
Blanco S; Ferrières J; Bongard V; Toulza O; Sebai F; Billet S; Biendel C; Lairez O; Lhermusier T; Boudou N; Campelo-Parada F; Roncalli J; Galinier M; Carrié D; Elbaz M; Bouisset F
Can J Cardiol; 2017 Jul; 33(7):933-939. PubMed ID: 28668143
[TBL] [Abstract][Full Text] [Related]
9. Impact of frailty on 30-day and 1-year mortality in hospitalised elderly patients with community-acquired pneumonia: a prospective observational study.
Luo J; Tang W; Sun Y; Jiang C
BMJ Open; 2020 Oct; 10(10):e038370. PubMed ID: 33130565
[TBL] [Abstract][Full Text] [Related]
10. A retrospective study on 73 elderly patients (≥75years) with aggressive B-cell non Hodgkin lymphoma: clinical significance of treatment intensity and comprehensive geriatric assessment.
Marchesi F; Cenfra N; Altomare L; Dessanti ML; Mecarocci S; Cerchiara E; Rago A; D'Andrea M; Tomarchio V; Olimpieri OM; Tirindelli MC; Mengarelli A; Petti MC; Avvisati G; Cimino G
J Geriatr Oncol; 2013 Jul; 4(3):242-8. PubMed ID: 24070462
[TBL] [Abstract][Full Text] [Related]
11. Frailty status changes are associated with healthcare utilization and subsequent mortality in the elderly population.
Li CM; Lin CH; Li CI; Liu CS; Lin WY; Li TC; Lin CC
BMC Public Health; 2021 Apr; 21(1):645. PubMed ID: 33794860
[TBL] [Abstract][Full Text] [Related]
12. Assessment of prevalence and clinical outcome of frailty in an elderly predialysis cohort using simple tools.
Ali H; Abdelaziz T; Abdelaal F; Baharani J
Saudi J Kidney Dis Transpl; 2018; 29(1):63-70. PubMed ID: 29456209
[TBL] [Abstract][Full Text] [Related]
13. Frailty in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Receiving Curative-Intent Therapy: A Population-Based Study.
Vijenthira A; Mozessohn L; Nagamuthu C; Liu N; Blunt D; Alibhai S; Prica A; Cheung MC
J Natl Compr Canc Netw; 2022 Jun; 20(6):635-642.e9. PubMed ID: 35714676
[TBL] [Abstract][Full Text] [Related]
14. Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysis.
Rampotas A; Wilson MR; Lomas O; Denny N; Leary H; Ferguson G; McKay P; Ebsworth T; Miller J; Shah N; Martinez-Calle N; Bishton M; Everden A; Tucker D; El-Hassad E; Hennessy B; Doherty D; Prideaux S; Faryal R; Hayat A; Keohane C; Marr H; Gibb A; Pocock R; Lambert J; Lacey R; Elmusharaf N; Clifford R; Eyre TA
Br J Haematol; 2021 Jul; 194(2):365-377. PubMed ID: 33959947
[TBL] [Abstract][Full Text] [Related]
15. Adjusted Chemotherapy According to Frailty Status in Elderly Patients With Diffuse Large B-Cell Lymphoma: Experience From a Single Referral Center in Mexico City.
Lastra-German IK; Navarrete-Reyes AP; Mejía-Domínguez NR; Agreda-Vásquez GP
Clin Lymphoma Myeloma Leuk; 2019 Feb; 19(2):e98-e106. PubMed ID: 30545670
[TBL] [Abstract][Full Text] [Related]
16. Poor quality of life in patients with and without frailty: co-prevalence and prognostic implications in patients undergoing percutaneous coronary interventions and cardiac catheterization.
Kanwar A; Roger VL; Lennon RJ; Gharacholou SM; Singh M
Eur Heart J Qual Care Clin Outcomes; 2021 Oct; 7(6):591-600. PubMed ID: 32821905
[TBL] [Abstract][Full Text] [Related]
17. Association between preoperative frailty and outcomes among adults undergoing cardiac surgery: a prospective cohort study.
Montgomery C; Stelfox H; Norris C; Rolfson D; Meyer S; Zibdawi M; Bagshaw S
CMAJ Open; 2021; 9(3):E777-E787. PubMed ID: 34285057
[TBL] [Abstract][Full Text] [Related]
18. Association of frailty and chemotherapy-related adverse outcomes in geriatric patients with cancer: a pilot observational study in Taiwan.
Ho YW; Tang WR; Chen SY; Lee SH; Chen JS; Hung YS; Chou WC
Aging (Albany NY); 2021 Nov; 13(21):24192-24204. PubMed ID: 34747717
[TBL] [Abstract][Full Text] [Related]
19. Frailty is an independent prognostic marker in elderly patients with myocardial infarction.
Alonso Salinas GL; Sanmartin M; Pascual Izco M; Rincon LM; Pastor Pueyo P; Marco Del Castillo A; Garcia Guerrero A; Caravaca Perez P; Recio-Mayoral A; Camino A; Jimenez-Mena M; Zamorano JL
Clin Cardiol; 2017 Oct; 40(10):925-931. PubMed ID: 28712144
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of geriatric assessment in combination with laboratory parameters in elderly patients with aggressive non-Hodgkin lymphoma.
Aaldriks AA; Giltay EJ; Nortier JW; van der Geest LG; Tanis BC; Ypma P; le Cessie S; Maartense E
Leuk Lymphoma; 2015 Apr; 56(4):927-35. PubMed ID: 24956143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
